Abstract: Background (13) C-Acetate labeled meals are widely used to determine meal emptying by means of analyzing resulting (13) CO(2) exhalation dynamics. In contrast to the underlying metabolic processes, only few (13) C breath test meal emptying studies have focused on intragastric processes that may alter (13) CO(2) exhalation. This work assessed the effect of enhanced gastric secretion on the reliability of half emptying time (t50) measurements by (13) C-acetate breath test. Methods (13) CO(2) exhalation data were acquired in a double-blind, randomized, cross-over gastric emptying study in 12 healthy volunteers receiving either pentagastrin or placebo intravenously. (13) 
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Abstract
Background: 13 C-Acetate labeled meals are widely used to determine meal emptying by means of analyzing resulting 13 CO 2 exhalation dynamics. In contrast to the underlying metabolic processes, only few 13 C breath test meal emptying studies have focused on intragastric processes that may alter 13 CO 2 exhalation. This work assessed the effect of enhanced gastric secretion on the reliability of half emptying time (t50) measurements by 13 C-acetate breath test.
Methods:
13 CO 2 exhalation data was acquired in a double-blind, randomized, crossover gastric emptying study in 12 healthy volunteers receiving either pentagastrin or placebo intravenously. The standard method proposed by Ghoos et al. was applied to calculate t50 (t50_Ghoos) from 13 CO 2 exhalation data, which was compared and tested for agreement to meal half emptying times (t50_MV) from concurrent recorded MRI volume data. In addition, the accumulated gastric secretion volumes during infusion as detected by MRI (AUC_SV 60 ) were correlated to the corresponding cumulative percent 13 C doses recovered (cPDR 60 ).
Key Results:
t50_Ghoos and t50_MV showed a linear correlation with a slope of 1.1±0. 
Volunteers and study design
Primary outcome of this work was the difference in meal emptying half time between 13 in a single center, double-blind, randomized, placebo-controlled and cross-over study design.
Randomization was assured by a computer generated random list and stratified with a 1:1 allocation using random block sizes of 6. The two study days were separated by 2 -14 days and each subject was investigated after an 8 h fasting period. Either pentagastrin (pgs; 0.6 µg kg -1 h -1
; Cambridge Laboratories, Wallsend, UK) or placebo (plc; sodium chloride 0.9% Baxter ® ; Baxter, Volketswil, Switzerland), was infused intravenously (IV) at time point t=0 min for 60 minutes. Volunteers ingested the test meal within 3 -5 min after IV infusion was started. Breath samples were taken in fasting state and then after meal intake at regular time intervals until 180 min. Concurrent MRI measurements were performed until 90 minutes after meal intake. Heart rate and blood pressure were monitored over the whole study period.
C-Acetate breath test and MRI data
To focus on the effect of stimulated gastric secretion on 13 CO 2 excretion, this work analyzed breath test and MRI data during the pentagastrin study arm only for the IV infusion period, i.e. until 60 min. After the end of pentagastrin infusion, MRI volume data showed a change in the dynamics of secretion and also for meal emptying and, therefore, standard analytical methods could no longer be applied for the entire dataset. 
Results

Breath test and MRI data
Visual inspection of the data revealed that 13 CO 2 exhalation measurements, expressed as cPDR and PDR, were lower during pentagastrin infusion compared to placebo in the majority of the volunteers ( figure 1A) . Also, concurrent meal volume decrease, as assessed by MRI, appeared to be slower and secretion volume larger during pentagastrin infusion compared to placebo ( figure 1B) . Both, breath test and MRI data, showed inter-individual variations during both placebo and pentagastrin infusion. 
Correlation and agreement of breath test and MRI data
Due to technical difficulties during pentagastrin treatment, breath test data of one volunteer was missing and excluded from the analyses.
Treatment independent, i.e. all data encompassing, half emptying times derived from breath test (t50_Ghoos) and treatment independent meal half emptying times derived from MRI 
Effect of pentagastrin stimulation on gastric meal emptying half time
Breath test and MRI data both revealed a longer t50 for the pentagastrin study arm ( figure   4A ). Table 1 shows the individual differences in t50 between pentagastrin and placebo. 
Discussion
To investigate the effect of enhanced gastric secretion on the reliability of meal emptying measurements by 13 C-acetate breath test, this work analyzed simultaneously acquired 13 Cacetate breath test data and meal emptying data recorded by MRI. Independent of the amount of gastric secretion, a linear correlation for the derived half emptying times (t50) was found between both methods and, compared to MRI, a large positive offset in t50 was determined for the 13 C breath test data analyzed by the method proposed by Ghoos et al. (14) As expected, pentagastrin caused a prolongation in meal half emptying times (12, 18) , that was detected with both methods. The prolongation in where an increase in gastric acid output after stimulation with gastrin derivates was seen after a comparable period. (19, 20) In all subjects, the detected cumulative 13 CO 2 exhalation dynamic was more related to the meal emptying dynamics than to the integrated volume of gastric secretion ( figure 3) . Breath test derived half emptying times (t50_Ghoos) were well correlated with the MRI derived meal half emptying times (t50_MV) ( figure 3A) , however, exhibited a considerable positive offset of 136 min in the Bland-Altman plot (figure 3B).
Positive offsets in t50 derived by the 13 C-acetate breath test have previously been described in other comparative imaging studies using ultrasonography and gamma-scintigraphy. larger offset for the calculated t50_Ghoos. However, the extent by which the offset in t50_Ghoos compared to t50_MV can be explained by the post-gastric metabolic processes or may be due to the applied standard analytical "Ghoos" method cannot be clearly deduced from this work. It may be suspected that it is also caused to a major part by the "Ghoos" method itself. Derivation of t50 by analyzing breath test data with other published methods, such as the method published by Bluck (28) , did also lead to t50 values that correlated with t50_MV, but showed different systematic offsets in half emptying times. Due to these inconsistencies between analysis techniques and the lack of a gold standard, the collected 13 C-acetate breath test data was analyzed using the widely accepted "Ghoos" method that has been previously validated for liquid emptying. However, the given data did not allow for robust separation of gastric secretion and/or pentagastrin induced effects on meal emptying. To exclude the potentially overwhelming effect of pentagastrin itself on motor inhibition, future studies on this topic should be designed using physiologic, non-pharmacologic secretion stimulation.
Considering that the range of changes in t50_Ghoos is comparable to the range of changes in t50_MV between pentagastrin and placebo infusion, it can be assumed that the endocrine pentagastrin effect is dominating over the intragastric secretion effect. Both methods detected a comparable prolonging effect of pentagastrin infusion on t50 with median [95% CI] differences in t50_Ghoos of 45 minutes and t50_MV of 37 minutes.
Therefore, it may be speculated that pentagastrin affects the emptying process as a whole (and thereby in a more constant manner), whereas secretion might possibly have led to a partial or local effect in the stomach (and subsequent on the Figure legends 
